Prothena: Fourth Quarter Financial Highlights

Prothena Corp. Announces Fourth Quarter Financial Results

Prothena Corp., headquartered in Dublin, disclosed on Thursday that it recorded a net loss of $21.6 million for the fourth quarter.

The company reported a quarterly loss of 40 cents per share. After accounting for restructuring-related gains, the adjusted loss amounted to 44 cents per share.

These figures were better than anticipated by analysts, as a consensus of four experts polled by Zacks Investment Research had predicted a loss of 45 cents per share.

During the quarter, the pharmaceutical firm generated $21,000 in revenue.

For the entire year, Prothena reported a total loss of $244.1 million, translating to $4.53 per share, with annual revenue reaching $9.7 million.